• 1
    Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2003;139: 893900.
  • 2
    Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant therapy. Chest. 2001;119: 108S21.
  • 3
    Cannegueter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333: 117.
  • 4
    Glasheen JJ, Fugit RV. How warfarin interacts with common antibiotics. Emerg Med. 2004;36: 30C30I.
  • 5
    Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121: 67683.
  • 6
    Penning-van Beest FJ, Van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther. 2001;69: 4517.
  • 7
    Panneerselvam S, Baglin C, Lefort W, Baglin T. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin. Br J Hematol. 1998;103: 4224.
  • 8
    Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician. 1999;59: 63546.
  • 9
    Beckey NP, Parra D, Colon A. Retrospective evaluation of a potential interaction between azithromycin and warfarin in patients stabilized on warfarin. Pharmacotherapy. 2000;20: 10559.
  • 10
    TatroDS, ed. Drug Interaction Facts. St. Louis, Mo: Facts and Comparisons; 2003.
  • 11
    McCall KL, Anderson HG, Jones AD. Determination of the lack of a drug interaction between azithromycin and warfarin. Pharmacotherapy. 2004;24: 18894.
  • 12
    Rindone JP, Kuey CL, Jones WN, Garewal HS. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin. Clin Pharm. 1991;10: 1368.
  • 13
    Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW. Potential warfarin–ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy. 1992;12: 4359.
  • 14
    Israel DS, Stotka J, Rock W, et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. CID. 1996;22: 2516.
  • 15
    Liao S, Palmer M, Fowler C, Nayak RK. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol. 1996;36: 10727.
  • 16
    Yamreudeewong W, Lower DL, Kipatrick DM, Enlow AM, Burrows MM, Greenwood MC. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy. Pharmacotherapy. 2003;23: 3338.
  • 17
    Glasheen JJ, Fugit RV, Prochazka AV. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy—a comment. Pharmacotherapy. 2003;23: 107980.
  • 18
    O'Reilly RA, Motley CH. Racemic warfarin and trimethoprim-sulfamethoxasole interaction in humans. Ann Intern Med. 1979;91: 346.